BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  FDA

  Novartis’ Tasigna Wins FDA Nod for First and Only CML Therapy With Treatment-Free Remission Data in Its Label

  Novartis announced today that the FDA approved the inclusion of Treatment-free Remission data in the Tasigna U.S. product label.

  December 22, 2017

   · 

  13 min read
• Helix BioPharma Corp. Closes Private Placement

  Helix BioPharma Corp. announced it has closed a private placement financing for gross proceeds of CAD750,600.

  December 22, 2017

   · 

  3 min read
• Viemed Commences Trading on the TSXV

  The common shares of Viemed (the “Viemed Shares”) will commence trading on the TSX Venture Exchange (the “TSXV”) on December 22, 2017 under the stock symbol “VMD”.

  December 22, 2017

   · 

  8 min read
• Business

  Humanigen Signs Definitive Agreements to Exchange Loan Obligations for Equity

  The transactions are expected to close in the first quarter of 2018 subject to the satisfaction of certain conditions contained in the definitive agreements.

  December 22, 2017

   · 

  7 min read
• BioMidwest

  DiaMedica Therapeutics Announces Results of Annual General and Special Meeting of Shareholders

  DiaMedica today announced that at its Annual General and Special Meeting of shareholders held on December 21, 2017.

  December 22, 2017

   · 

  2 min read
• Venus Medtech Release: First Successful Clinical Implantation of Transcatheter Pulmonary Valve VenusP-Valve was Successfully Completed in Brazil

  On December 19, 2017, local time, 4 clinical implantations of transcatheter pulmonary valve VenusP-Valve were successfully completed in Brazil by Professor Carlos Pedra from Dante Pazzanese Institute of Cardiovascular Technology in Sao Paulo, Brazil.

  December 22, 2017

   · 

  2 min read
• Business

  GBT Appoints Wendy L. Yarno to Board of Directors

  Ms. Yarno has more than 25 years of experience in the biopharmaceutical industry, including serving as chief marketing officer at Merck.

  December 22, 2017

   · 

  6 min read
• Business

  THERADIAG Signs a Partnership Agreement for Monitoring of Remicade

  Theradiag today announced that it had signed a partnership with MSD France to supply its LISA TRACKER kits for the monitoring of Remicade.

  December 22, 2017

   · 

  2 min read
• Biotech Bay

  Frost & Sullivan Projects CRISPR Technology Will be Fastest Growing Gene Editing Market Segment

  Frost & Sullivan expects that multiple applications of CRISPR genome editing technology can generate almost $25B in revenue by 2030s.

  December 22, 2017

   · 

  3 min read
• Drug Development

  Glycotope Initiates Phase Ib Trial of Combination of Proprietary Anti-Tumor Antibodies

  Glycotope today announces it has enrolled the first patient in its international GATTO study which combines two of the Company’s immuno-oncology assets derived from its world-leading glycobiology expertise.

  December 22, 2017

   · 

  4 min read